149 related articles for article (PubMed ID: 20501505)
41. Low-dose capecitabine (Xeloda) for treatment for gastrointestinal cancer.
Miger J; Holmqvist A; Sun XF; Albertsson M
Med Oncol; 2014 Mar; 31(3):870. PubMed ID: 24510794
[TBL] [Abstract][Full Text] [Related]
42. Photoeruption in a patient treated with capecitabine (Xeloda) for metastatic breast cancer.
Willey A; Glusac EJ; Bolognia JL
J Am Acad Dermatol; 2002 Sep; 47(3):453. PubMed ID: 12196762
[No Abstract] [Full Text] [Related]
43. Focal acral hyperpigmentation in a patient undergoing chemotherapy with capecitabine.
Villalón G; Martín JM; Pinazo MI; Calduch L; Alonso V; Jordá E
Am J Clin Dermatol; 2009; 10(4):261-3. PubMed ID: 19489659
[TBL] [Abstract][Full Text] [Related]
44. Low-dose capecitabine in breast cancer patients with symptomatic bone marrow infiltration: a case study.
Ardavanis A; Kountourakis P; Orphanos G; Rigatos G
Anticancer Res; 2008; 28(1B):539-41. PubMed ID: 18383899
[TBL] [Abstract][Full Text] [Related]
45. [Breast cancer and the hand-foot syndrome].
Llambrich C; Falcou MC; De Rycke Y; Cottu P; Carrié S; Medjbari M
Soins; 2012 Jun; (766):25-8. PubMed ID: 22870762
[TBL] [Abstract][Full Text] [Related]
46. [New therapeutic prospects with capecitabin in breast carcinoma].
Venturini M; Catzeddu T
Tumori; 2002; 88(1):A1-6. PubMed ID: 12008671
[No Abstract] [Full Text] [Related]
47. Capecitabine in colorectal, breast, and other solid tumors: novel therapeutic approaches. Selected abstracts from ASCO 2003.
Oncology (Williston Park); 2003 Aug; 17(8 Suppl 8):10-62; quiz 63-4. PubMed ID: 14570064
[No Abstract] [Full Text] [Related]
48. Optimizing chemotherapy dose and schedule by Norton-Simon mathematical modeling.
Traina TA; Dugan U; Higgins B; Kolinsky K; Theodoulou M; Hudis CA; Norton L
Breast Dis; 2010; 31(1):7-18. PubMed ID: 20519801
[TBL] [Abstract][Full Text] [Related]
49. DCA increases the antitumor effects of capecitabine in a mouse B16 melanoma allograft and a human non-small cell lung cancer A549 xenograft.
Zheng MF; Shen SY; Huang WD
Cancer Chemother Pharmacol; 2013 Nov; 72(5):1031-41. PubMed ID: 24043136
[TBL] [Abstract][Full Text] [Related]
50. [Adjuvant therapy of colonic carcinoma--soon in tablet form].
Krankenpfl J; 2004; 42(5-6):157. PubMed ID: 15527221
[No Abstract] [Full Text] [Related]
51. [Oral combination chemotherapy with capecitabine and cyclophosphamide in combination with endocrine therapy and anti-HER2 therapy for advanced and metastatic breast cancer].
Okamura R; Kato T; Sata R
Nihon Rinsho; 2012 Sep; 70 Suppl 7():592-6. PubMed ID: 23350469
[No Abstract] [Full Text] [Related]
52. Capecitabine.
Schellens JH
Oncologist; 2007 Feb; 12(2):152-5. PubMed ID: 17296810
[No Abstract] [Full Text] [Related]
53. How the new oral antineoplastics affect nursing practice: capecitabine serves to illustrate.
Szetela AB; Gibson DE
Am J Nurs; 2007 Dec; 107(12):40-8; quiz 48-9. PubMed ID: 18049060
[TBL] [Abstract][Full Text] [Related]
54. Phase II study of capecitabine plus trastuzumab in human epidermal growth factor receptor 2 overexpressing metastatic breast cancer pretreated with anthracyclines or taxanes.
Schaller G; Fuchs I; Gonsch T; Weber J; Kleine-Tebbe A; Klare P; Hindenburg HJ; Lakner V; Hinke A; Bangemann N
J Clin Oncol; 2007 Aug; 25(22):3246-50. PubMed ID: 17577021
[TBL] [Abstract][Full Text] [Related]
55. Contemporary issues and the potential uses of capecitabine in metastatic breast cancer.
Barrett-Lee P; Bidard FC; Pierga JY
Cancer Treat Rev; 2009 Nov; 35(7):582-9. PubMed ID: 19632050
[TBL] [Abstract][Full Text] [Related]
56. Results of a phase I trial of intravenous vinorelbine plus oral capecitabine as first-line chemotherapy of metastatic breast cancer.
Favier L; Isambert N; Zanetta S; Ferrant E; Mayer F; Chauffert B; Fumoleau P; Garnier J; Biville F; Coudert B
Breast; 2008 Feb; 17(1):36-41. PubMed ID: 17698359
[TBL] [Abstract][Full Text] [Related]
57. Moderate dose capecitabine in older patients with metastatic breast cancer: a standard option for first line treatment?
Kotsori AA; Noble JL; Ashley S; Johnston S; Smith IE
Breast; 2010 Oct; 19(5):377-81. PubMed ID: 20392643
[TBL] [Abstract][Full Text] [Related]
58. [Use of xeloda (capecitabine) in the treatment of cancer patients (review)].
Orel NF
Ter Arkh; 2003; 75(10):65-70. PubMed ID: 14669610
[No Abstract] [Full Text] [Related]
59. Capecitabine-related cardiotoxicity: recognition and management.
Saif MW; Tomita M; Ledbetter L; Diasio RB
J Support Oncol; 2008 Jan; 6(1):41-8. PubMed ID: 18257400
[No Abstract] [Full Text] [Related]
60. Oral fluoropyrimidines in cancer treatment.
Lewis NL; Meropol NJ
Cancer Invest; 2000; 18(8):747-60. PubMed ID: 11107445
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]